Prediction research in neuroleptic therapy — future directions

  • W. Gaebel
  • A. G. Awad
Conference paper


Prognosis (Gk. prognosis) means to know in advance. To predict (Lat. praedicere) means to state, tell about or make known in advance. Prediction is the more technical term compared to prognosis. Prognosis is a prediction especially of the probable course of a disease. This makes clear that in prediction research we deal with probabilities. One aim of this kind of research is to increase the probability of correct prediction. The clinical aim is to improve the course of illness by tailoring the treatment to the individual patient.


Vulnerability Model Illness Characteristic Prediction Research Neuroleptic Therapy Treatment Outcome Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Key selected references.

  1. Awad AG (1993) Methodological and design issues in clinical trials of new neuroleptics: an overview. Br J Psychiatry 163[Suppl 22]: 51–57.Google Scholar
  2. Carpenter WT, Heinrichs DW, Hanlon TE (1981) Methodologic standards for treatment outcome research in schizophrenia. Am J Psychiatry 138: 465–471.PubMedGoogle Scholar
  3. Clements K, Turpin G (1992) Vulnerability models and schizophrenia: the assessment and prediction of relapse. In: Birchwood M, Tarrier N (eds) Innovations in the psychological management of schizophrenia. Wiley, Chichester New York Brisbane Toronto Singapore, pp 21–47.Google Scholar
  4. Engel GL (1980) The clinical application of the biopsycho-social model. Am J Psychiatry 137: 535–544.PubMedGoogle Scholar
  5. Gaebel W, Renfordt E (eds) (1989) Objective methods for behavioral analysis in psychiatry and psychopharmacology — examples and concepts. Pharmacopsychiatry 22[Suppl]: 1–50.Google Scholar
  6. Helmchen H, Gaebel W (1987) Strategies of clinical research on neurobiological determinants of psychosis. Psychiatr Dev 5: 51–62.PubMedGoogle Scholar
  7. Hsiao JK, Bartko JJ, Potter WZ (1989) Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry. Arch Gen Psychiatry 46: 664–667.PubMedCrossRefGoogle Scholar
  8. Kissling W (ed) (1991) Guidelines for neuroleptic relapse prevention in schizophrenia. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  9. May PRA, Van Putten T, Yale C, Potepan P, Jenden DJ, Fairchild MD, Goldstein MJ, Dixon WJ (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 162: 177–183.PubMedCrossRefGoogle Scholar
  10. May PRA, Goldberg SC (1978) Prediction of schizophrenic patients’ response to pharmacotherapy. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1139–1153.Google Scholar
  11. Nuechterlein KH (1987) Vulnerability models for schizophrenia: state of the art. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 297–316.CrossRefGoogle Scholar
  12. Van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML (1987) Denosologization of biological psychiatry or the specifity of 5-HT disturbances in psychiatric disorders. J Affect Disord 13: 1–8.PubMedCrossRefGoogle Scholar
  13. Woggon B, Baumann U (1983) Multimethodological approach in psychiatric predictor research. Pharmacopsychiatry 16: 175–178.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1994

Authors and Affiliations

  • W. Gaebel
  • A. G. Awad

There are no affiliations available

Personalised recommendations